Skip to main content
APURES CO., LTD. logo

APURES CO., LTD. — Investor Relations & Filings

Ticker · 149300 ISIN · KR7149300006 KO Professional, scientific and technical activities
Filings indexed 196 across all filing types
Latest filing 2018-11-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 149300

About APURES CO., LTD.

https://www.apures.com/

APURES CO., LTD. is a biotechnology company specializing in research and development solutions centered on its proprietary "MICROPIG" platform. This internationally registered minipig model, which is anatomically and physiologically similar to humans, serves as a foundation for the company's diverse offerings. APURES develops and supplies standard and transgenic MICROPIG models, along with a portfolio of derived bio-resources including organs, tissues, and standardized primary cells for cell-based assays. The company provides comprehensive non-clinical contract research organization (CRO) services, offering integrated in-vitro and in-vivo testing solutions tailored for new drug development. Additionally, APURES is advancing into therapeutic innovation, developing bio-materials for xenotransplantation and tissue engineering, and pursuing the development of its own pipeline of gene therapies.

Recent filings

Filing Released Lang Actions
분기보고서 (2018.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '메디키네틱스(주)' covering the period from January 1, 2018, to September 30, 2018. It contains detailed financial statements, management discussion, and operational information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2018
2018-11-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.